Lumacaftor/ivacaftor, a novel agent for the treatment of cystic fibrosis patients who are homozygous for the F580del CFTR mutation.
about
Lumacaftor/ivacaftor, a novel agent for the treatment of cystic fibrosis patients who are homozygous for the F580del CFTR mutation.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Lumacaftor/ivacaftor, a novel ...... for the F580del CFTR mutation.
@en
Lumacaftor/ivacaftor, a novel ...... for the F580del CFTR mutation.
@nl
type
label
Lumacaftor/ivacaftor, a novel ...... for the F580del CFTR mutation.
@en
Lumacaftor/ivacaftor, a novel ...... for the F580del CFTR mutation.
@nl
prefLabel
Lumacaftor/ivacaftor, a novel ...... for the F580del CFTR mutation.
@en
Lumacaftor/ivacaftor, a novel ...... for the F580del CFTR mutation.
@nl
P2093
P2860
P1476
Lumacaftor/ivacaftor, a novel ...... for the F580del CFTR mutation.
@en
P2093
Cameron Hanna
Marilyn N Bulloch
Richard Giovane
P2860
P304
P356
10.1080/17512433.2017.1378094
P407
P577
2017-09-11T00:00:00Z